EpilepsiaPub Date : 2026-11-14Epub Date: 2026-09-01DOI: 10.1002/epi.70439
Chiara Cancellerini, Alice Caravelli, Martina Soldà, Erika Esposito, Luca Vignatelli, Barbara Mostacci, Jessica Fiori, Francesca Bisulli, Laura Licchetta
{"title":"Real-world evaluation of capillary microsampling for drug monitoring of anti-seizure medications","authors":"Chiara Cancellerini, Alice Caravelli, Martina Soldà, Erika Esposito, Luca Vignatelli, Barbara Mostacci, Jessica Fiori, Francesca Bisulli, Laura Licchetta","doi":"10.1002/epi.70439","DOIUrl":"10.1002/epi.70439","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Capillary microsampling offers a minimally invasive alternative to venipuncture for therapeutic drug monitoring (TDM) of anti-seizure medications (ASMs). We evaluated the feasibility and reliability of volumetric absorptive microsampling (VAMS) and quantitative dried blood spot (qDBS) devices for ambulatory self-collection and at-home use in persons with epilepsy (PwE).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>PwE attending the Epilepsy Centre of the IRCCS-Istituto delle Scienze Neurologiche di Bologna (Italy) were enrolled between October 2023 and October 2024. Participants performed supervised self-collection using VAMS and qDBS in ambulatory setting and at-home self-collection with VAMS devices. Sample quality, delivery success, and patient-reported outcomes (ease, pain, and clarity of instructions) were recorded. Carbamazepine, lacosamide, lamotrigine, and levetiracetam were quantified using a validated ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS) method. Reliability was assessed by comparing at-home VAMS with ambulatory VAMS and cross-validating qDBS with VAMS and venous plasma samples using Bland–Altman analysis and linear regression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 105 PwE (66% female, mean age 41 years) performed at-home and ambulatory self-collection using VAMS and qDBS devices. Most at-home VAMS samples (88%) were received by the laboratory within 7 days, and 86.8% met high-quality criteria. For lacosamide, lamotrigine, and levetiracetam, we found strong correlations between at-home and ambulatory VAMS (Pearson's <i>r</i> ranging from .88 to .98) and low mean bias (<1.0 μg/mL). Conversely, carbamazepine showed lower reliability (<i>r</i> = .31; <i>p</i> = .49; bias = 2.05 μg/mL). Cross-validation of qDBS vs plasma confirmed good agreement (slope = .92, .63–1.21) with no significant systematic bias. Patient feedback indicated that self-collection was easy and minimally painful, although age>60 years impacted sampling quality, particularly for qDBS (<i>p</i> = .04).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>VAMS-based self-collection is feasible and reliable for at-home TDM, provided that high-quality sampling is ensured. qDBS represents a reliable alternative for ambulatory monitoring. Future work should focus on optimizing sampling procedures for older adults and improving logistics for home-based microsampling.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5703-5714"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70439","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148873494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-12DOI: 10.1002/epi.70411
Philippe Gélisse, William O. Tatum, Arielle Crespel, Peter W. Kaplan
{"title":"Response to Ng et al. on “Stimulus-induced arousal with transient electroencephalographic improvement distinguishes nonictal from ictal generalized periodic discharges”","authors":"Philippe Gélisse, William O. Tatum, Arielle Crespel, Peter W. Kaplan","doi":"10.1002/epi.70411","DOIUrl":"10.1002/epi.70411","url":null,"abstract":"<p>As the century began, Niedermeyer and Ribeiro<span><sup>1</sup></span> cautioned against broad application of the emerging concept of nonconvulsive status epilepticus (NCSE). They stressed that true NCSE was rare. Moreover, many cases classified as NCSE in patients who were critically ill did not fulfill the criteria.<span><sup>1</sup></span> They illustrated this distinction graphically, separating “true NCSE” from “false NCSE.” Absence status epilepticus (ASE) and NCSE in critically ill patients have very different clinical profiles. Patients with ASE are usually able to walk into the clinic, and unlike NCSE in critically ill patients, patients with ASE rarely require intensive care unit (ICU) admission (true NCSE). The reactivity to various forms of stimulation in our article was used as a bedside method to help the clinician identify nonictal patterns in their patients where a question of NCSE was present.<span><sup>2</sup></span> Niedermeyer's “true” NCSE is the best example of NCSE, which is characterized by unreactive electroencephalographic (EEG) activity.</p><p>The framework proposed by Ng et al. contains three principal elements: first, a neutral or descriptive characterization of generalized periodic discharges (GPDs); second, classification of those patterns as ictal or nonictal according to the patient's response to a trial of antiseizure medication (ASM); and third, the ultimate diagnosis of NCSE based on the pharmacologic response.<span><sup>3</sup></span> Yet exposing every patient who is suspected of manifesting NCSE to trials of ASM raises potential safety concerns. This concern is heightened in the elderly and across other vulnerable populations. Due to various disorders that can cause NCSE, many patients have ages at onset clustering in the mid-60s<span><sup>4</sup></span> to the early-to-mid 70s.<span><sup>5, 6</sup></span> Intravenous benzodiazepines (BZPs) may cause marked sedation, and loading doses of other antiseizure agents can be difficult for frail patients to tolerate. Valproate, when administered as a loading dose, carries a risk of hyperammonemia.<span><sup>7</sup></span> Phenytoin loading in elderly patients should be approached with caution due to an increased risk of cardiovascular instability, including hypotension and arrhythmias. BZDs or phenobarbital—even a single dose—can worsen hepatic encephalopathy, with a risk of prolonged stupor or coma.</p><p>Ng et al. argue that our article rests on problematic assumptions and imply “the cause of GPDs can be identified with sufficient reliability on EEG alone.” In this article, we sought to clarify that the underlying “cause” when addressed by reactivity may aid clinicians in differentiating ictal from nonictal patterns on EEG. GPDs with triphasic morphology are nonspecific patterns that may be encountered in acute encephalopathies, including postanoxia. However, they are also observed in basal meningitis, in Creutzfeldt–Jakob disease (CJD; Figure 1), and in sever","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5600-5606"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70411","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148724429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14DOI: 10.1002/epi.70584
Vineet Punia, Marian Galovic, Francesco Brigo, Eugen Trinka, Ronit Pressler
{"title":"Etiology and geographic variation in acute symptomatic seizure management: An international vignette-based survey.","authors":"Vineet Punia, Marian Galovic, Francesco Brigo, Eugen Trinka, Ronit Pressler","doi":"10.1002/epi.70584","DOIUrl":"https://doi.org/10.1002/epi.70584","url":null,"abstract":"<p><strong>Objective: </strong>Acute symptomatic seizures (ASyS) account for nearly half of new onset seizures, but evidence guiding management remains limited. We aimed to characterize international variation in ASyS management across common etiologies.</p><p><strong>Methods: </strong>We conducted a cross-sectional, vignette-based survey through the International League Against Epilepsy national chapters (February to May 2025). Five etiology-based vignettes assessed clinical and electrographic ASyS scenario after ischemic stroke, traumatic brain injury (TBI), meningitis, hyponatremia, and alcohol withdrawal. Respondents who managed neonatal seizures completed a neonatal stroke vignette. We assessed antiseizure medication (ASM) initiation, duration after clinical ASyS, and continuous electroencephalography (cEEG) use. Interrespondent variability was quantified by normalized Shannon entropy (H'). Multivariable generalized estimating equations accounted for repeated responses.</p><p><strong>Results: </strong>Among 963 respondents (92 countries), 62% recommended ASM initiation in clinical and 61% in electrographic ASyS scenarios. Overall ASM initiation variability was high (H' = .96), highest for alcohol withdrawal (H' = 1.0), followed by stroke (H' > .9), and consistently higher for electrographic than clinical ASyS. Etiology was the strongest driver of ASM initiation. Compared with stroke, ASM initiation odds were higher for TBI (odds ratio [OR] = 2.5, 95% confidence interval [CI] = 2.2-2.8) and meningitis (OR = 1.9, 95% CI = 1.7-2.2), and lower for hyponatremia (OR = .2, 95% CI = .2-.2) and alcohol withdrawal (OR = .5, 95% CI = .5-.6). Compared with Europe, initiation odds were higher in North America (OR = 2.7, 95% CI = 2.0-3.6), Asia-Oceania (OR = 2.4, 95% CI = 2.0-3.0), and Latin America (OR = 2.0, 95% CI = 1.5-2.7), but not Africa. These differences persisted after accounting for country income. Compared with stroke, the mean ASM duration was 3.2 months shorter for hyponatremia and .6 months longer for TBI. Alcohol withdrawal durations were polarized (41% discontinued at discharge; 20% continued >12 months). cEEG use was markedly higher in North America than Europe (OR = 11.3, 95% CI = 7.8-16.5). Among 291 neonatal respondents, 75% continued ASM beyond discharge.</p><p><strong>Significance: </strong>ASyS management varies markedly, reaching near-maximal heterogeneity in several common scenarios. Although etiology drives decisions, geography and provider characteristics also influence care, underscoring an urgent need for randomized trials and international consensus guidance to harmonize care.</p>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-07-30DOI: 10.1002/epi.70406
Meixuan Ren, Cuiping Xu, Na Clara Pan, Runshi Gao, Wei Shu, Xueyuan Wang, Xi Zhang, Li Wang, Liping Zhang, Xiaoming Yan, Xiaohua Zhang, Tao Yu, Mohamad Z Koubeissi, Yuping Wang
{"title":"Electroclinical features and dynamic network connectivity of orbitofrontal epilepsy","authors":"Meixuan Ren, Cuiping Xu, Na Clara Pan, Runshi Gao, Wei Shu, Xueyuan Wang, Xi Zhang, Li Wang, Liping Zhang, Xiaoming Yan, Xiaohua Zhang, Tao Yu, Mohamad Z Koubeissi, Yuping Wang","doi":"10.1002/epi.70406","DOIUrl":"10.1002/epi.70406","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Orbitofrontal epilepsy (OFE) is rare and underrecognized. This study aims to characterize electroclinical features and dynamic network connectivity of OFE and subtypes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively analyzed 17 patients with OFE who underwent stereoelectroencephalographic (SEEG) electrode implantation and epilepsy surgery at our center. Thirteen patients with available ictal SEEG recordings were further categorized into lateral (LOFE, <i>n</i> = 6), medial (MOFE, <i>n</i> = 5), and posterior (POFE, <i>n</i> = 2) subtypes. Clinical semiology, scalp electroencephalographic (EEG), neuroimaging, and SEEG data were analyzed. Directed functional connectivity was evaluated in 22 seizures from 13 patients using pairwise nonlinear regression across ictal stages.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The mean seizure duration was 68.4 s. Semiology was heterogeneous, with impaired consciousness being the most common manifestation (47.1%), frequently evolving into elementary motor phenomena (62.5%) or automatisms (37.5%). Hyperkinetic behavior (23.5%) and focal to bilateral tonic–clonic seizures (29.4%) were also observed. This heterogeneity may relate to propagation to frontal, cingulate, insular, and temporal regions. In 13 patients with available ictal SEEG recordings, EEG seizure activity preceded clinical onset, with a mean electroclinical delay of 28.9 s. LOFE most often showed nonspecific auras and early motor manifestations; MOFE was associated with autonomic auras and automatisms; and POFE frequently presented with fear auras. Functional connectivity increased from early to late ictal periods and remained elevated postictally. Connectivity differences between LOFE and MOFE were confined to the seizure onset and early propagation phases, with LOFE showing stronger lateral frontal interactions and MOFE stronger medial frontal–cingulate/insula interactions. SEEG resolved frequent mislocalizations by scalp EEG/imaging. Most patients achieved favorable outcomes (Engel class I: 84.6%, mean follow-up = 52.1 months, 11/13), and focal cortical dysplasia was the most common pathology (76.9%, 10/13).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>OFE subtypes tend to show different semiological features and preferential connectivity patterns, potentially related to differential engagement of frontal–limbic networks. Targeted SEEG is associated with accurate localization and generally favorable outcomes in this cohort.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5628-5641"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70406","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148619013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-04DOI: 10.1002/epi.70415
Alexandria Valdrighi, Kevin Pearsson, Jurriaan Peters, Tarrant McPherson, Yuchen Li, Ann Hyslop, Yiming Gan, George Nageeb, H. Westley Phillips, Vivek Buch, Kelly Mahaney, Laura Prolo, Brenda Porter
{"title":"Epilepsy outcomes following single and repeat epilepsy surgeries in tuberous sclerosis complex","authors":"Alexandria Valdrighi, Kevin Pearsson, Jurriaan Peters, Tarrant McPherson, Yuchen Li, Ann Hyslop, Yiming Gan, George Nageeb, H. Westley Phillips, Vivek Buch, Kelly Mahaney, Laura Prolo, Brenda Porter","doi":"10.1002/epi.70415","DOIUrl":"10.1002/epi.70415","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Epilepsy surgery in tuberous sclerosis complex (TSC) is underutilized but associated with improved seizure control and better neurocognitive outcomes. Here we focus on utilization of repeated surgeries to improve seizure control.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We performed a retrospective chart review of 62 pediatric patients with TSC, who underwent a total of 120 epilepsy surgeries at Boston Children's Hospital and Stanford University from 2011 to 2025. We collected patient seizure control over time, following single or multiple surgeries, details of the surgery performed, the location(s) and timing of post-operative seizure recurrence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Twenty-nine patients (47%) had a single surgery and 33 (53%) underwent repeat epilepsy surgeries. There were no significant differences in surgical approaches (laser vs open) or demographic or clinical factors between patients with single vs repeated surgeries. Patients with one or two surgeries had similar rates of seizure freedom from the targeted epileptic foci: 76% single and 66% two or more surgeries. Overall seizure freedom from all foci was 69% for a single surgery and 55% for two or more surgeries. Seizure freedom rates for the targeted foci decreased following the third through fifth surgeries, but some patients still achieved overall seizure freedom: 33% following the third and 40% the fourth surgery.</p>\u0000 \u0000 <p>Seizure recurrences were primarily from prior targeted foci (57%), but 29% were from new foci that became clinically apparent after the first surgery. The presence of interictal epileptiform activity prior to surgery had modest sensitivity 75% (25/33) for prediction of an eventual seizure focus. Timing of surgery had some impact on outcome, with earlier surgery associated with increased seizure freedom.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>Repeat surgeries whether near a prior surgical site or addressing a novel seizure focus have the potential to render most children with TSC seizure-free. Earlier surgery had some evidence for improving outcomes and timing of surgery should be studied in greater detail.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5642-5652"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148668758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-01DOI: 10.1002/epi.70416
Gloria Ortiz-Guerrero, Asra Tanwir, Ashar Farooqi, Sihyeong Park, Gamaleldin Osman, Keith Starnes, Brian N. Lundstrom, Gregory A. Worrell, Kai J. Miller, Jamie J. Van Gompel, Nicholas M. Gregg
{"title":"Pulvinar and anterior nucleus of the thalamus dual-network neuromodulation for complex epilepsies","authors":"Gloria Ortiz-Guerrero, Asra Tanwir, Ashar Farooqi, Sihyeong Park, Gamaleldin Osman, Keith Starnes, Brian N. Lundstrom, Gregory A. Worrell, Kai J. Miller, Jamie J. Van Gompel, Nicholas M. Gregg","doi":"10.1002/epi.70416","DOIUrl":"10.1002/epi.70416","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS) is an effective therapy for frontotemporal and limbic drug-resistant focal epilepsies. The pulvinar nucleus (PUL) is an emerging neuromodulation target for seizure networks involving the posterior quadrant and temporal lobe. This study evaluates the safety and effectiveness of combined bilateral ANT plus PUL DBS for posterior quadrant and temporal lobe epilepsies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a single-center retrospective cohort study of patients receiving combined ANT/PUL DBS between 2021 and 2025. Outcomes included median seizure rate reduction (MSR), responder rate (RR; >50% seizure frequency reduction), and stimulation-related side effects, assessed across ANT, PUL, and concurrent ANT/PUL stimulation settings. Acute surgical complications were evaluated. Statistical significance was assessed using two-sided Wilcoxon signed-rank tests with Holm–Bonferroni correction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Nine patients with combined ANT/PUL DBS were identified, and eight patients had sufficient follow-up for inclusion (median follow-up = 20 months). Posterior predominant structural abnormalities were present in eight of nine patients. There were no acute surgical complications. Three instances of transient stimulation-related side effects resolved with parameter adjustments, whereas one patient required rescue antiseizure medication in addition to programming changes. Eight patients received periods of ANT stimulation, six PUL stimulation, and seven combined ANT/PUL stimulation. Regarding overall outcome, at last follow-up, there was a significant 80.8% MSR (<i>p</i> = .0078) and 87.5% RR, with two patients receiving ANT and six ANT/PUL stimulation. Regarding target-specific MSR, concurrent ANT/PUL DBS (68.8% MSR) showed a trend toward superior performance relative to ANT (43.3%) and PUL DBS (17.5%) alone, although subgroup analysis of target-specific performance did not reach statistical significance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>Combined four-lead ANT/PUL DBS appears safe and effective for patients with drug-resistant posterior quadrant and temporal lobe epilepsies. Dual-network neuromodulation may provide greater flexibility to individually optimize neuromodulation for complex seizure networks.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5743-5754"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148653258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-19DOI: 10.1002/epi.70423
John M. Stern, Leock Y. Ngo, Eric B. Segal, Danielle A. Becker, Randa G. Jarrar, Tracy A. Glauser, Jurriaan M. Peters, Emilio Perucca, Evelyn K. Shih, Enrique Carrazana, Adrian L. Rabinowicz
{"title":"Outcomes of out-of-hospital treatment of impending tonic–clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis","authors":"John M. Stern, Leock Y. Ngo, Eric B. Segal, Danielle A. Becker, Randa G. Jarrar, Tracy A. Glauser, Jurriaan M. Peters, Emilio Perucca, Evelyn K. Shih, Enrique Carrazana, Adrian L. Rabinowicz","doi":"10.1002/epi.70423","DOIUrl":"10.1002/epi.70423","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>We assessed the timing, dosing, and effectiveness of diazepam nasal spray in a large dataset of seizures treated in the out-of-hospital setting, using as reference the International League Against Epilepsy criteria for tonic–clonic status epilepticus (SE) and its treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We analyzed pooled data from two studies evaluating the use of diazepam nasal spray as acute treatment for seizures in the out-of-hospital setting, a phase 1/2a pharmacokinetics and safety study (patients aged 2–5 years) and a phase 3 long-term safety study (patients aged 6–65 years). For this analysis, tonic–clonic SE episodes were defined as seizures lasting beyond time point <i>t</i><sub>1</sub> (5 min). Responder analyses examined SE termination by time point <i>t</i><sub>2</sub> (30 min after seizure start) and SE termination ≤20 min after dose administration. SE recurrence at ≤1, 12, and 24 h after SE termination was also assessed. Rate of SE episodes for which ≥2 doses of diazepam nasal spray were administered was a proxy for effectiveness. We also reported safety data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of episodes with sufficient data for classification, a total of 402 episodes were categorized as tonic–clonic SE. The majority of tonic–clonic SE episodes terminated by <i>t</i><sub>2</sub> (248 [61.7%]) and nearly half terminated within 20 min after dose administration (200 [49.8%]). SE recurrence after SE termination was low, with <5% of tonic–clonic SE episodes followed by a recurrence in ≤24 h. Rate of usage of ≥2 doses for tonic–clonic SE episodes was low (5% [20 seizure episodes]). Serious treatment-emergent events of SE occurred in 6.6% of patients with tonic–clonic SE episodes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>These findings support the safety and effectiveness of diazepam nasal spray for treating episodes of tonic–clonic SE and strengthen the evidence of the benefits of immediate-use antiseizure medication for seizure emergencies, including early SE.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5692-5702"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70423","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14DOI: 10.1002/epi.70595
Moisés León-Ruiz, Pablo Sánchez-González
{"title":"Comment on \"Sick sinus syndrome: A harbinger of anti-LGI1 encephalitis\".","authors":"Moisés León-Ruiz, Pablo Sánchez-González","doi":"10.1002/epi.70595","DOIUrl":"https://doi.org/10.1002/epi.70595","url":null,"abstract":"","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-18DOI: 10.1002/epi.70419
Dario J. Englot
{"title":"Perils and progress in epilepsy surgery utilization: Twenty-five years later","authors":"Dario J. Englot","doi":"10.1002/epi.70419","DOIUrl":"10.1002/epi.70419","url":null,"abstract":"<p>More than 25 years have passed since the first randomized controlled trial (RCT) established that surgery is superior to continued anti-seizure medication (ASM) for drug-resistant temporal lobe epilepsy, and nearly as long since a joint practice parameter urged that appropriate surgical candidates be referred to a specialized center for evaluation—guidance that subsequent consensus has since broadened to all patients with drug-resistant epilepsy. Despite Class I evidence and durable guidelines, epilepsy surgery remains one of the most underutilized effective interventions in medicine: fewer than 1% of potentially eligible patients are referred, and those who are referred reach a center on average two decades after seizure onset. This critical review, framed primarily around U.S. data and supplemented by a dedicated assessment of the global picture, examines the scope and burden of drug-resistant epilepsy (DRE), the foundational evidence and guideline history, and the magnitude, patterns, and causes of persistent underutilization, including a distinct discussion of pediatric care and of disparities by race, insurance, and geography. We then turn to grounds for optimism. Surgical candidacy has materially expanded through minimally invasive approaches to both monitoring (stereo-electroencephalography) and treatment (laser interstitial thermal therapy and neuromodulation), and indications have broadened to include selected generalized and multifocal epilepsies through thalamic neuromodulation. Contemporary International League Against Epilepsy (ILAE) recommendations go further still, extending referral even to selected patients who are seizure-free on medication but harbor a surgically accessible lesion. We also raise a counterbalancing concern: the welcome diffusion of minimally invasive options should not eclipse resective and disconnective surgery, which remain the only potentially curative options validated by RCTs. We conclude that, 25 years on, underutilization persists as a major and partly remediable problem, and we offer recommendations for closing the surgical gap.</p>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5563-5576"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70419","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EpilepsiaPub Date : 2026-11-14Epub Date: 2026-08-17DOI: 10.1002/epi.70424
Victoria Wong, Ewan S. Nurse, Ashley Reynolds, Mark J. Cook, Philippa J. Karoly
{"title":"Monthly or menstrual? A scoping review of catamenial epilepsy and non-menstrual seizure rhythms","authors":"Victoria Wong, Ewan S. Nurse, Ashley Reynolds, Mark J. Cook, Philippa J. Karoly","doi":"10.1002/epi.70424","DOIUrl":"10.1002/epi.70424","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Despite the reported high prevalence of catamenial epilepsy (CE), the condition remains poorly defined, with lack of consensus on what entails a menstrual-related seizure exacerbation. Emerging evidence of multiday cycles of seizure activity, including about-monthly cycles, present in both men and women, further confound the existence of CE. Issues of misdiagnosis, attribution bias, and potentially inappropriate hormonal therapies are relevant downstream effects of poorly defined CE. The purpose of this focused review was to examine the current literature on defining CE, alongside non-specific monthly seizure cycles, and appraise the most commonly utilized diagnostic methods. Against this background, we aim to identify limitations with current CE diagnostics in order to improve the methods of studying epilepsy chronobiology.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A scoping review on all primary source literature reporting on CE using the Ovid MEDLINE and EMBASE databases was conducted. Studies were limited to clinical trials and case reports, which were then classified by the CE definition utilized and length of diagnostic monitoring. This was repeated for literature on non-specific, multidien seizure cycles.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Overall, 70 CE studies were included of the 233 studies screened (30.0%). Of these, most did not define or specify CE criteria utilized (52.9%). Studies predominantly did not specify the duration of seizure and menstrual-data recording before the establishment of a CE diagnosis (47.1%), and if specified, was most frequently for 3 months or less (32.9%). In general, the literature on multidien seizure cycles (<i>n</i> = 33) had longer average recording periods (24 months), more multimodal recording, balanced sexes, and conducted more significance testing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>Current definitions on CE are fragmented in the literature. The common methods of workup cannot reliably differentiate CE from other monthly rhythms evident equally in men, women, and children. Current time-based diagnoses of CE have limited ability to extrapolate into an accurate long-term rhythm.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"67 11","pages":"5755-5780"},"PeriodicalIF":5.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epi.70424","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148758205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}